THIS IS A FIRM FIXED PRICE CONTRACT FOR DEVELOPMENT OF MODERNIZED SUSCEPTIBILITY GUIDANCE FOR AMPICILLIN AND VANCOMYCIN FOR ENTEROCOCCUS SPECIES USING PHARMACOMETRIC APPROACHES
$263,016
| Recipient | INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC. UEI Z82HHPY83MC7 |
|---|---|
| Award ID | 75F40123C00140 |
| Award amount | $263,016 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Food and Drug Administration |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | B529 |
| Start date | Sep 18, 2023 |
| End date | Sep 29, 2024 |
| Place of performance | SCHENECTADY, NY |
| Record updated | Jul 30, 2025 |
View the official award record
More awards won by INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.
PRE-CLINICAL MODELS OF INFECTIOUS DISEASES - TASK AREA C
Department of Health and Human Services · $146,300,000 · Jul 15, 2024
BAA CONTRACT - DEVELOPMENT OF SUSCEPTIBILITY GUIDANCE FOR DAPTOMYCIN AND ENTEROCOCCUS SPECIES USING PHARMACOMETRIC APPROACHES
Department of Health and Human Services · $325,000 · Aug 1, 2026
COMBATTING ANTIBIOTIC RESISTANT BACTERIA (CARB) PROGRAM
Department of Health and Human Services · $291,618 · Sep 21, 2022
A STUDY IN THE "DEVELOPMENT OF MODERNIZED SUSCEPTIBILITY GUIDANCE FOR ORAL SULFAMETHOXAZOLE-TRIMETHOPRIM USING PHARMACOMETRICS APPROACHES" BAA PMWP #195
Department of Health and Human Services · $291,142 · Sep 22, 2022
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids